42 related articles for article (PubMed ID: 1982091)
1. Parasympathetic nervous system in patients with Graves' disease determined by R-R interval variations on electrocardiogram.
Inukai T; Kobayashi I; Kobayashi T; Ishii A; Yamaguchi T; Yamaguchi Y; Iwashita A; Shimomura Y; Kobayashi S
Exp Clin Endocrinol; 1990 Dec; 96(3):289-95. PubMed ID: 1982091
[TBL] [Abstract][Full Text] [Related]
2. Influence of thyrotropin-releasing hormone on autonomic nervous system determined by the variations in R-R interval on electrocardiogram.
Iwashita A; Kobayashi I; Inukai T; Takahashi M; Ishii A; Ohshima K; Mori M; Shimomura Y; Kobayashi S
Exp Clin Endocrinol; 1990 Sep; 96(1):121-4. PubMed ID: 2126239
[TBL] [Abstract][Full Text] [Related]
3. Power spectral analysis of variations in heart rate in patients with hyperthyroidism or hypothyroidism.
Inukai T; Takanashi K; Kobayashi H; Fujiwara Y; Tayama K; Aso Y; Takemura Y
Horm Metab Res; 1998 Aug; 30(8):531-5. PubMed ID: 9761386
[TBL] [Abstract][Full Text] [Related]
4. Parasympathetic nervous system activity in hypothyroidism determined by R-R interval variations on electrocardiogram.
Inukai T; Kobayashi I; Kobayashi T; Ishii A; Yamaguchi T; Yamaguchi Y; Iwashita A; Ohshima K; Shimomura Y; Kobayashi S
J Intern Med; 1990 Nov; 228(5):431-4. PubMed ID: 2254712
[TBL] [Abstract][Full Text] [Related]
5. [A study of hemodynamic effects during dental treatment under local anesthesia. Observation of parasympathetic activity based on the index of R-R interval variation in ECG].
Kawano T
Shikwa Gakuho; 1990 Feb; 90(2):135-60. PubMed ID: 2135091
[TBL] [Abstract][Full Text] [Related]
6. Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability.
Chen JL; Chiu HW; Tseng YJ; Chu WC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):611-6. PubMed ID: 16712661
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of coefficient of variation of R-R interval in ECG for patients with impotence].
Takasaki N; Kotani T; Miyazaki S; Saitou S
Hinyokika Kiyo; 1989 Aug; 35(8):1361-4. PubMed ID: 2816601
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of parasympathetic nerve function in patients with extrinsic bronchial asthma--evaluation by coefficiency of variance of R-R interval with modified long-term ECG monitoring system.
Hashimoto A; Maeda H; Yokoyama M
Kobe J Med Sci; 1996 Dec; 42(6):347-59. PubMed ID: 9153972
[TBL] [Abstract][Full Text] [Related]
9. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
10. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
[TBL] [Abstract][Full Text] [Related]
11. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.
Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG
Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411
[TBL] [Abstract][Full Text] [Related]
12. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
13. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
Wakelkamp IM; Prummel MF; Wiersinga WM
Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
[TBL] [Abstract][Full Text] [Related]
14. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
Bürgi U; Gerber H; Peter HJ
Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
[TBL] [Abstract][Full Text] [Related]
15. Thyroid cancer yield in patients with Graves' disease.
Stocker DJ; Burch HB
Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602
[TBL] [Abstract][Full Text] [Related]
16. Effects of atipamezole--a selective alpha-adrenoceptor antagonist--on cardiac parasympathetic regulation in human subjects.
Penttilä J; Kaila T; Helminen A; Anttila M; Karhuvaara S; Huhtala S; Scheinin H
Auton Autacoid Pharmacol; 2004 Jul; 24(3):69-75. PubMed ID: 15541014
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
Inukai T; Takanashi K; Takebayashi K; Fujiwara Y; Tayama K; Takemura Y
Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968
[TBL] [Abstract][Full Text] [Related]
18. Serum immunoglobulin E and soluble CD23 in patients with Graves' disease.
Sayinalp S; Akalin S; Sayinalp N; Erbaş T; Bayraktar M; Ozcebe OI; Dündar S; Kirazli S
Horm Metab Res; 1996 Mar; 28(3):133-7. PubMed ID: 8926012
[TBL] [Abstract][Full Text] [Related]
19. Food choice in hyperthyroidism: potential influence of the autonomic nervous system and brain serotonin precursor availability.
Pijl H; de Meijer PH; Langius J; Coenegracht CI; van den Berk AH; Chandie Shaw PK; Boom H; Schoemaker RC; Cohen AF; Burggraaf J; Meinders AE
J Clin Endocrinol Metab; 2001 Dec; 86(12):5848-53. PubMed ID: 11739450
[TBL] [Abstract][Full Text] [Related]
20. Impaired decision making under risky conditions in the acute phase of Graves' thyroitoxicosis.
Dai F; Yuan L; Fang J; Zhang Q; Wang K
Neurosci Lett; 2017 Nov; 661():1-4. PubMed ID: 28859864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
